Computational toxicology methods in public health practice

Toxicology Mechanisms and Methods

Volumn 18, Issue 2-3, 2008, Pages 119-135

  Demchuk, Eugene ^a   Ruiz, Patricia ^a   Wilson, Jewell D ^a   Scinicariello, Franco ^a   Pohl, Hana R ^a   Fay, Mike ^a   Mumtaz, Moiz M ^a   Hansen, Hugh ^a   De Rosa, Christopher T ^a  

^a AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

Author keywords

BMD; Chemical Mixture; Computational Toxicology; CSAF; HGV; MRL; PBPK; QSAR; Risk Assessment; Structure Activity

Indexed keywords

AGRICULTURAL CHEMICAL; ORGANIC SOLVENT; VOLATILE ORGANIC COMPOUND;

CHEMICAL INTERACTION; CHEMICAL MODEL; CLINICAL PRACTICE; COST; EXPERIMENTAL MODEL; GENETICS; HEALTH HAZARD; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; LABORATORY TEST; NONHUMAN; PHARMACOKINETICS; PHYSIOLOGY; PRIORITY JOURNAL; PUBLIC HEALTH; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; SENSITIVITY AND SPECIFICITY; TOXICOLOGY; UNCERTAINTY;

ANIMALIA; GB VIRUS C;

EID: 40949145717     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376510701857148     Document Type: Review

References (106)

1. Agency for Toxic Substances and Disease Registry (ATSDR). 2004a Guidance Manual for the Assessment of Joint Toxic Action of Chemical Mixtures, May 2004. U.S. DHHS PHS ATSDR Atlanta, GA. http://www.atsdr.cdc. gov/interactionprofiles/ipga.html. Accessed October 26, 2007.
2. Agency for Toxic Substances and Disease Registry (ATSDR). 2004b. Interaction Profile for Benzene, Toluene, Ethylbenzene, and Xylenes. U.S. DHHS PHS ATSDR. Atlanta, GA. 2004b http://www.atsdr.cdc.gov/ interactionprofiles/ip05.html. Accessed October 26, 2007.
3. Agency for Toxic Substances and Disease Registry (ATSDR). 2006a. Toxicological Profile for 1,1,2,2-Tetrachloroethane, U.S. DHHS PHS ATSDR, Atlanta, GA. http://www.atsdr.cdc.gov/toxprofiles/tp93.html. Accessed October 26, 2007.
4. Agency for Toxic Substances and Disease Registry (ATSDR). 2006b. Interaction Profile for Atrazine, Deethylatrazine, Diazinon, Nitrate and Simazine. U.S. DHHS PHS ATSDR Atlanta, GA 2006b http://www.atsdr.cdc.gov/ interactionprofiles/ip10.html. Accessed October 26, 2007.
5. Agency for Toxic Substances and Disease Registry (ATSDR). 2007a. Minimal Risk Levels. U.S. DHHS PHS ATSDR. Atlanta, GA. http://www.atsdr.cdc.gov/mrls/index.html. Accessed October 26, 2007.
6. Agency for Toxic Substances and Disease Registry (ATSDR). 2007b. Hazardous Substance Release and Health Effects Database (HazDat). U.S. DHHS PHS ATSDR. Atlanta GA. http://www.atsdr.cdc.gov/hazdat.html. Accessed October 26, 2007.
7. Agency for Toxic Substances and Disease Registry (ATSDR). 2007c. Toxicological Profile for Boron. U.S. DHHS PHS ATSDR Atlanta, GA. http://www.atsdr.cdc.gov/toxprofiles/tp26.html. Accessed October 26, 2007.
8. Agency for Toxic Substances and Disease Registry (ATSDR). 2007d. Interaction Profiles. U.S. DHHS PHS ATSDR, Atlanta, GA. http://www. atsdr.cdc.gov/interactionprofiles. Accessed October 26, 2007.
9. Agency for Toxic Substances and Disease Registry (ATSDR). 2007e. Interaction Profile for Chloroform, 1,1-Dichloroethylene, Trichloroethylene, and Vinyl Chloride. U.S. DHHS PHS ATSDR, Atlanta, GA. http://www.atsdr.cdc. gov/interactionprofiles/ip13.html. Accessed October 26, 2007.
10. Akaike, H. 1974. A new look at the statistical model identification. IEEE T. Automatic Con. 19:716-723.
11. Anand, S. S., Mumtaz, M. M., and Mehendale, H. M. 2005. Dose-dependent liver regeneration in chloroform, trichloroethylene and allyl alcohol ternary mixture hepatotoxicity in rats. Arch. Toxicol. 79:671-682.
12. Andersen, M. E., Clewell, H. J., Gargas, M. L., Macnaughton, M. G., Reitz, R. H., Nolan, R. J., and McKenna, M. J. 1991. Physiologically based pharmacokinetic modeling with dichoromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans. Toxicol. Appl. Pharm. 108:14-27.
13. Andersen, M. E., Clewell, H. J., Gargas, M. L., Smith, F. A., and Reitz, R. H. 1987a. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharm. 87:185-205.
14. Andersen, M. E., Gargas, M. L., Clewell, H. J., and Severyn, K. M. 1987b. Quantitative evaluation of the metabolic interactions between trichloroethylene and 1,1-dichloroethylene in vivo using gas uptake methods. Toxicol. Appl. Pharm 89:149-157.
15. Barton, H. A., Creech, J. R., Godin, C. S., Randall, G. M., and Seckel, C. S. 1995. Chloroethylene mixtures: pharmacokinetic modeling and in vitro metabolism of vinyl chloride, trichloroethylene, and trans-1,2-dichloroethylene in rat. Toxicol. Appl. Pharm. 130:237-247.
16. Basak, S. C., Mills, D., El-Masri, H. A., Mumtaz, M., and Hawkins, D. M. 2004. Predicting blood:air partition coefficients using theoretical molecular descriptors. Environ. Toxicol. Pharm. 16:45-55.
17. Béliveau, M., Tardif, R., and Krishnan, K. 2003. Quantitative structure-property relationships for physiologically based pharmacokinetic modeling of volatile organic chemicals in rats. Toxicol. Appl. Pharm. 189:221-232.
18. Benfenati, E., and Gini, G. 1997. Computational predictive programs (expert systems) in toxicology. Toxicology 119:213-225.
19. Benigni, R., and Richard, A. M. 1996. QSARs of mutagens and carcinogens: two case studies illustrating problems in the construction of models for noncongeneric chemicals. Mutat. Res. 371:29-46.
20. Benigni, R., and Richard, A. M. 1998. Quantitative structure-based modeling applied to the characterization and prediction of chemical toxicity. Methods 14:264-276.
21. Chemical Abstracts Service. 2007. Registry Number and Substance Counts, American Chemical Society, Columbus, OH. http://www.cas.org/cgi-bin/ cas/regreport.pl. Accessed October 26, 2007.
22. Chou, C., Holler, J. S., and De Rosa, C. T. 1998. Minimal risk levels for hazardous substances. J. Clean Technol. Environ. Toxicol. Occup. Medicine 7:1-24.
23. Cova, D., Nebuloni, C., Arnoldi, A., Bassoli, A., Trevisan, M., and DelRe, A. A. 1996. N-nitrosation of triazines in human gastric juice. J. Agric. Food Chem. 44:2852-2855.
24. Davidson, P. W., Myers, G. J., Cox, C., Shamlaye, C. F., Marsh, D. O., Tanner, M. A., Berlin, M., Sloane-Reeves, J., Cernichiari, E., Choisy, O., Choi, A., and Clarkson, T. W. 1995. Longitudinal neurodevelopmental study of Seychellois children following in utero exposure to methylmercury from maternal fish ingestion: Outcome at 19 and 29 months. Neurotoxicology 16:677-688.
25. Demchuk, E., Yucesoy, B., Johnson, V. J., Weston, A., Germolec, D., De Rosa, C. T., and Luster, M. I. 2007. A statistical model to assess genetic susceptibility as a risk factor in multifactorial diseases: Lessons from occupational asthma. Environ. Health Persp. 115:231-234.
26. De Rosa, C. T. 1995. Charge to workshop. Toxicol. Lett. 79:7-8.
27. De Rosa, C. T., El-Masri, H. E., Pohl, H., Cibulas, W., and Mumtaz, M. M. 2004. Implications of chemical mixtures for public health practice. J. Toxicol. Environ. Health 7:339-350.
28. Dourson, M., Maier, A., Meek, B., Renwick, A., Ohanian, E., and Poirier, K. 1998. Boron tolerable intake re-evaluation of toxicokinetics for data derived uncertainty factors. Biol. Trace. Elem. Res. 66:453-463.
29. Dunlop, W. 1981. Serial changes in renal haemodynamics during normal human pregnancy. Br. J. Obstet. Gynecol. 88:1-9.
30. Durkin, P., Hertzberg, R., Stiteler, W., and Mumtaz, M. 1995. The identification and testing of interaction patterns (LOAEL). Toxicol. Lett. 79:251-226.
31. EC. 2006. Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Off. J. Eur. Union 49, L396.
32. Eisenbrand, G., Ungerer, O., and Preussmann, R. 1975. Formation of N nitroso compounds from agricultural chemicals and nitrite. In: Bogovski, P., Walker, E. A., and Davis, W. (Eds.), N-nitroso Compounds in the Environment, International Agency for Research on Cancer, Switzerland, pp. 71-74.
33. El-Masri, H. A., Constan, A. A., Ramsdell, H. S., and Yang, R. S. 1996a. Physiologically based pharmacodynamic modeling of an interaction threshold between trichloroethylene and 1,1-dichloroethylene in Fischer 344 rats. Toxicol. Appl. Pharm. 141:124-132.
34. El-Masri, H. A., Mumtaz, M. M., Choudhary, G., Cibulas, W., and De Rosa, C. T. 2002. Applications of computational toxicology methods at the Agency for Toxic Substances and Disease Registry. Int. J. Hyg. Environ. Health 205:63-69.
35. El-Masri, H. A., Mumtaz, M. M., and Yushak, M. L. 2004. Application of physiologically based pharmacokinetic modeling to investigate the toxicological interaction between chlorpyrifos and parathion in the rat. Environ. Toxicol. Pharmacol. 16:57-71.
36. El-Masri, H. A., Tessari, J. D., and Yang, R. H. 1996b. Exploration of an interaction threshold for the joint toxicity of trichloroethylene and 1,1-dichloroethlene: utilization of a PBPK model. Arch. Toxicol. 70:527-539.
37. Elsevier Information Systems GmbH. 2007. CrossFire Beilstein database exceeds ten million compounds. Press release, August 20th 2007. http://www.beilstein.com/PR Beilstein%2010m Final.pdf. Accessed October 26, 2007.
38. Enomoto, N., Takase, S., Yasuhara, M., and Takada, A. 1991. Acetaldehyde metabolism in different aldehyde dehydrogenase-2 genotypes. Alcohol Clin. Exp. Res. 15:141-144.
39. Enslein, K. 1993. The future of toxicity prediction with QSAR. In Vitro Toxicol. 6:163-169.
40. Fine, D. H., Rounbehler, D. P., Belcher, N. M., and Epstein, S. S. 1976. N-nitroso compounds in air and water. Environmental N-nitroso Compounds Analysis and Formation: Proceedings of a Working Conference Held at the Polytechnical Institute, Tallinn, Estonian SSR, International Agency for Research on Cancer, WHO, Publication No. 14, Lyon, France, pp. 401-408.
41. Gearhart, J.M., Clewell, H. J., Crump, K. S., Shipp, A.M., and Silvers, A. 1995. Pharmacokinetic dose estimates of mercury in children and dose-response curves of performance tests in large epidemiological study. Water Air Soil Pollut. 80:49-58.
42. Goedde, H. W., Agarwal, D. P., Fritze, G., Meier-Tackmann, D., Singh, S., Beckmann, G., Bhatia, K., Chen, L. Z., Fang, B., and Lisker, R. 1992. Distribution of ADH2 and ALDH2 genotypes in different populations. Hum. Genet. 88:344-346.
43. Haddad, S., Béliveau, M., Tardif, R., and Krishnan, K. 2001. A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures. Toxicol. Sci. 63:125-131.
44. Haddad, S., Charest-Tardif, G., Tardif, R., and Krishnan, K. 2000. Validation of a physiological modeling framework for simulating the toxicokinetics of chemicals in mixtures. Toxicol. Appl. Pharm. 167:199-209.
45. Haddad, S., Tardif, R., Charest-Tardif, G., and Krishnan, K. 1999. Physiological modeling of the toxicokinetics interactions in a quaternarymixture of aromatic hydrocarbons. Toxicol. Appl. Pharm. 161:249-257.
46. Hansch, C., Hoekman, D., Leo, A., Zhang, L., and Li, P. 1995. The expanding role of quantitative structure-activity relationships (QSAR) in toxicology. Toxicol. Lett. 79:45-53.
47. Hansch, C., and Leo, A. 1995. Exploring QSAR. Fundamentals and Applications in Chemistry and Biology, American Chemical Society, Washington DC.
48. Heindel, J. J., Price, C. J., Field, E. A., Marr, M. C., Myers, C. B., Morrissey, R. E., and Schwetz, B. A. 1992. Developmental toxicity of boric acid in mice and rats. Fund. Appl. Toxicol. 18:266-277.
49. International Commission on Radiological Protection. 1975. Reference Man: Anatomical, Physiological and Metabolic Characteristics, ICRP Publication no. 23, Elsevier, New York.
50. International Programme on Chemical Safety. 2001. Guidance Document for the Use of Data in Development of Chemical Specific Adjustment Factors (CSAFs) for Interspecies Differences and Human Variability in Dose/Concentration Response Assessment, World Health Organization, Geneva, Switzerland.
51. International Programme on Chemical Safety. 2005. Chemical-Specific Adjustment Factors for Interspecies Differences and Human Variability: Guidance Document for Use of Data in Dose/Concentration-Response Assessment. Harmonization Project Document No. 2, World Health Organization, Geneva, Switzerland.
52. Isaacs, K. K., Evans, M. V., and Harris, T. R. 2004. Visualization-based analysis for a mixed-inhibition binary PBPK model: determination of inhibition mechanism. J. Pharmacokinet. Pharmacodyn. 31:215-242.
53. Ishidate, M. 1983. Application of chromosomal aberration tests in vitro to the primary screening for chemicals with carcinogenic and/or genetic hazards. In: Garattini, S. (Ed.), Tests courts de cancérogénèse: Quo vadis?, Centre de Recherches Clin Midy, Montpellier, France, pp. 57-79.
54. Ishidate, M., Sofuni, T., and Yoshikawa, K. 1981. Chromosomal aberration tests in vitro as a primary screening tool for environmental mutagens and/or carcinogens. GANN Monogr. Cancer Res. 27:95-108.
55. Jaeger, R. J., Conolly, R. B., Reynolds, E. S., and Murphy, S. D. 1975. Biochemical toxicology of unsaturated halogenated monomers. Environ. Health Perspect. 11:121-128.
56. Johnson, B. L., and De Rosa, C. T. 1997. The toxicologic hazard of superfund hazardous waste sites. Rev. Environ. Health 12:235-251.
57. Juhl, G. A., Kim, E. H., Benitez, J. G., and Mangione, S. 2003. A community exposure to 2-chloro-6-fluorophenol. Vet. Hum. Toxicol. 45:41-42.
58. Karanth, S., Olivier, K., Liu, J., and Pope, C. 2001. In vivo interaction between chlorpyrifos and parathion in adult rats: sequence of administration canmarkedly influence toxic outcome. Toxicol. Appl. Pharmacol. 177:247-255.
59. Kearney, P. C., Oliver, J. E., Helling, C. S., Isensee, A. R., and Kontson, A. 1977. Distribution, movement, persistence, and metabolism of N nitrosoatrazine in soils and a model aquatic ecosystem. J. Agric. Food Chem. 25:1177-1181.
60. Klopman, G. 1984. Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules. J. Amer. Chem. Soc. 106:7315-7320.
61. Krull, I. S., Mills, K., Hoffman, G., and Fine, D. H. 1980. The analysis of N-nitrosoatrazine and N-nitrosocarbaryl in whole mice. J. Anal. Toxicol. 4:260-262.
62. Krutzen, F., Olofsson, P., Back, S. E., and Nilsson-Ehle, P. 1992. Glomerular filtration rate in pregnancy; a study in normal subjects and in patients with hypertension, preeclampsia and diabetes. Scand. J. Clin. Lab. Invest. 52:387-392.
63. Lehman, A. J., and Fitzhugh, O. G. 1954. 100-fold margin of safety. Assoc. Food Drug Off. U.S. Q. Bull. 18:33-35.
64. Macey, R., Oster, G., and Zahnley, T. 2000. Berkeley Madonna User's Guide, Version 5.0, University of California, Berkeley, CA. http://www.berkeleymadonna.com. Accessed October 26, 2007.
65. Meisner, L. F., Roloff, B. D., and Belluck, D. A. 1993. In vitro effects of N-nitrosoatrazine on chromosome breakage. Arch. Environ. Contam. Toxicol 24:108-112.
66. Mirvish, S. S., Gannett, P., Babcook, D. M., Williamson, D., Chen, S. C., and Weisenburger, D. D. 1991. N-nitrosoatrazine: synthesis, kinetics of formation, and NMR spectra and other properties. J. Agric. Food Chem. 39:1205-1210.
67. Mizoi, Y., Yamamoto, K., Ueno, Y., Fukunaga, T., and Harada, S. 1994. Involvement of genetic polymorphism of alcohol and aldehyde dehydrogenases in individual variation of alcohol metabolism. Alcohol Alcohol 29:707-710.
68. Mumtaz, M. M., and Durkin, P. R. 1992. A weight-of-evidence approach for assessing interactions in chemical mixtures. Toxicol. Ind. Health 8:377-406.
69. Mumtaz, M. M., Knauf, L. A., Reisman, D. J., Peirano, W. B., De Rosa, C. T., Gombar, V. K., Enslein, K., Carter, J. R., Blake, B. W., and Huque, K. I. 1995. Assessment of effect levels of chemicals from quantitative structure-activity relationship (QSAR) models. I. Chronic lowest-observed- adverse-effect level (LOAEL). Toxicol. Lett. 79:131-143.
70. Mumtaz, M. M., Ruiz, P., and De Rosa, C. T. 2007. Toxicity assessment of unintentional exposure to multiple chemicals. Toxicol. Appl. Pharm. 223:104-113.
71. National Center for Environmental Health 2005.Third National Report on Human Exposure to Environmental Chemicals. Pub. No. 05-0570 CDC, Atlanta, GA.
72. National Research Council. 1994a. Science and Judgment in Risk Assessment, National Academies Press, Washington DC, p. 79.
73. National Research Council. 1994b. Science and Judgment in Risk Assessment, National Academies Press, Washington DC, p. 144.
74. National Research Council. 2006. Human Biomonitoring for Environmental Chemicals, National Academies Press, Washington DC.
75. The National Toxicology Program. 2004. NTP Technical Report on the Toxicity Studies of 1,1,2,2-Tetrachloroethane Administered in Microcapsules in Feed to F-344/N Rats and B6C3F1 Mice. NIH Publication No. 04-4414.
76. The National Toxicology Program. 2007. National Toxicology Program. Department of Health and Human Services. http://ntp.niehs.nih.gov. Accessed October 26, 2007.
77. Padilla, S., Wilson, V. Z., and Bushnell, P. J. 1994. Studies on the correlation between cholinesterase inhibition and target tissue inhibition in pesticide-treated rats. Toxicology 92:11-25.
78. Pahl, M. V., Culver, B. D., Strong, P. L., Murray, F. J., and Vaziri, N. D. 2001. The effect of pregnancy on renal clearance of boron in humans: a study based on normal dietary intake of boron. Toxicol. Sci. 60:252-256.
79. Parham, F. M., Kohn, M. C., Matthews, H. B., De Rosa, C. T., and Portier, C. J. 1997. Using structural information to create physiologically based pharmacokinetic models for all polychlorinated biphenyls: I. Tissue:blood partition coefficients. Toxicol. Appl. Pharm. 144:340-334.
80. Pimentel, D., Cooperstein, S., Randell, H., Filiberto, D., Sorrentino, S., Kaye, B., Nicklin, C., Yagi, J., Brian, J., O'Hern, J., Habas, A., and Weinstein, C. 2007. Ecology of ncreasing diseases: population growth and environmental degradation. Hum. Ecol. 35:653-668.
81. Pohl, H. R., Roney, N., Wilbur, S., Hansen, H., and De Rosa, C. T. 2003. Six interaction profiles for simple mixtures. Chemosphere 53:183-197.
82. Price, C. J., Strong, P. L., Marr, M. C., Myers, C. B., and Murray, F. J. 1996. Developmental toxicity NOAEL and postnatal recovery in rats fed boric acid during gestation. Fund. Appl. Toxicol. 32:179-193.
83. Reitz, R. H., Hays, S. M., and Gargas, M. L. 1997. Addressing Priority Data Needs for Methylene Chloride with Physiologically Based Pharmacokientic Modeling, RHR Consulting Services, Midland, MI, and ChemRisk Division, McLaren/Hart, Cleveland, OH. Prepared for ATSDR on behalf of the Halogenated Solvents Industry Alliance, 1-38.
84. Reitz, R. H., Mendrala, A. L., Park, C. N., Andersen, M. E., and Guengerich, F. P. 1988. Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PB-PK) model for methylene chloride: implications for risk assessment. Toxicol. Lett 43:97-116.
85. Russell, W. M. S., and Burch, R. L. 1959. The Principles of Humane Experimental Technique. Methuen London.
86. Sanderson, D. M., and Earnshaw, C. G. 1991. Computer prediction of possible toxic action from chemical structure; the DEREK system. Hum. Exp. Toxicol. 10:261-273.
87. Sanderson, S., Emery, J., and Higgins, J. 2005. CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis. Genet. Med. 7:97-104.
88. Schou, J. S., Jansen, J. A., and Aggerbeck, B. 1984. Human pharmacokinetics and safety of boric acid. Arch. Toxicol. 7:232-235.
89. Schwetz, B. A., Leong, P. J., and Gehring, P. J. 1975. The effects of maternally inhaled trichloroethylene, perchloroethane, methyl chloroform, and methylene chloride on embryonal and fetal development in mice and rats. Toxicol. Appl. Pharm. 32:84-96.
90. Scinicariello, F., and De Rosa, C. T. 2007. Genetic heterogeneity and its effect on susceptibility to environmental factors. Eur. J. Oncol. 12:155-170.
91. Sturgiss, S. N., Wilkinson, R., and Davison, J. M. 1996. Renal reserve during human pregnancy. Am. J. Physiol. 271:F16-F20.
92. Tardif, R., Charest-Tarif, G., Brodeur, J., and Krishnan, K. 1997. Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans. Toxicol. Appl. Pharmacol. 144:120-134.
93. U.S. Census Bureau. 2002. Census 2000 Basics. US Census Bureau, Washington DC.
94. U.S. Census Bureau. 2006. http://quickfacts.census.gov/qfd. Accessed October 26, 2007.
95. U.S. Environmental Protection Agency. 1986. Guidelines for the Health Risk Assessment of Chemical Mixtures. Federal Register, vol 51 185, 34014-34025.
96. U.S. Environmental Protection Agency. 2002. Supplementary Guidance for Conducting Heath Risk Assessment of Chemical Mixtures. EPA/630/R-00/002. 2000a. http://cfpub.epa.gov/ncea/raf/chem mix.cfm. Accessed October 26, 2007.
97. U.S. Environmental Protection Agency. 2007a. National Priorities List Sites in the United States, U.S. EPA, Washington, DC. http://www.epa.gov/ superfund/sites/npl/npl.htm. Accessed October 26, 2007.
98. U.S. Environmental Protection Agency. 2007b. High Production Volume (HPV) Challenge Program, U.S. EPA, Washington, DC. http://www.epa.gov/hpv/ index.htm. Accessed October 26, 2007.
99. Vanderpool, R. A., Hof, D., and Johnson, P. E. 1994. Use of inductively coupled plasma-mass spectrometry in boron-10 stable isotope experiments with plants, rats, and humans. Environ. Health Perspect. 102(Suppl 7):13-20.
100. Vaziri, N. D., Oveisi, F., Culver, B. D., Pahl, M. V., Andersen, M. E., Strong, P. L., and Murray, F. J. 2001. The effect of pregnancy on renal clearance of boron in rats given boric acid orally. Toxicol. Sci. 60:257-263.
101. Welsh, C. J., Moffet, D., El-Masri, H., Fowler, D., and Moore, S. 2003. Evaluation of PCB exposure routes in Anniston, Alabama: assessment of fish consumption using PBPK modeling of PCB congeners in locally-caught fish. Toxicologist 72:364.
102. Williams-Johnson, M. M., Henriques, W., and Fay, R. M. 1996. Investigating ratios of health effect levels using ATSDR's HazDat database: Extrapolation methodologies in quantitative risk assessment. J. Clean. Technol. Environ. Toxicol. Occup. Med. 5:347-360.
103. Wilson, J. D., Cibulas, W., Choudhary, G., Mumtaz, M. M., and De Rosa, C. T. 2002. The use of decision-support tools to enhance health risk assessments at the Agency for Toxic Substances and Disease Registry. In: De Rosa, C. T., Holler, J. S., and Mehlman, M. A. (Eds.), Impact of Hazardous Chemicals on Public Health, Policy and Service, International Toxicology Books, Inc., Princeton, NJ, pp. 179-200.
104. Winneke, G. 1974. Behavioral effects of methylene chloride and carbon monoxide as assessed by sensory and psychomotor performance. In: Xintaras, C., Johnson, B. L., and de Groot, I. (Eds.), Behavioral Toxicology, U.S. Government Printing Office, Washington DC, pp. 130-144.
105. Wolfe, N. L., Zepp, R. G., Gordon, J. A., and Fincher, R. C. 1976. N-nitrosamine formation from atrazine. B. Environ. Contam. Toxicol. 15:342-347.
106. Woo, Y., Lai, D., Argus, M., and Arcos, J. 1995. Development of structure-activity relationship rules for predicting carcinogenic potential of chemicals. Toxicol. Lett. 79:219-228.